Certain prostate cancer medications are linked with an increased risk of dying from heart-related causes in men with congestive heart failure or prior heart attacks, a new study reveals. Published in iBJU International/i, the findings will help doctors and patients weigh the benefits and risks of the drugs. Androgen deprivation therapy (ADT), which reduces levels of male hormones in the body to prevent them from stimulating cancer cells, is a mainstay ...
Read More
No comments:
Post a Comment